VAR2 PHARMACEUTICALS ApS: Financial statements 2014
CVR: 34621942
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
VAR2 PHARMACEUTICALS ApS (CVR 34621942) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -828,912 and a net result of DKK -1,013,312 compared with DKK 65,528 the year before. Equity in the 2014 report amounted to DKK 905,760. The solvency ratio was 81.5%.
- Gross Profit
- DKK -828,912
- Profit/Loss
- DKK -1,013,312
- Equity
- DKK 905,760
- Total Assets
- DKK 1,111,995
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -829 t. | -1 mio. | 906 t. | - |
| 2013 | - | 68 t. | 66 t. | 118 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
VAR2 PHARMACEUTICALS ApS has published its annual report for 2013. Gross profit came to DKK 68,068, and the net result was DKK 65,528.
About VAR2 PHARMACEUTICALS ApS
VAR2 PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ali El-Salanti and Mads Daugaard. The board consists of Mads Daugaard (chair), Ali El-Salanti, Josef Rainer and Peter Schröcksnadel. The company is owned by ONCOMAL ApS and Københavns Universitet. The company has 10 employees (2026). In 2025, the company reported a gross profit of DKK -21,739,014 and a net result of DKK -19,726,508 compared with DKK -21,006,013 the year before. Equity in the 2025 report amounted to DKK 82,032,248.